Dr.Nowreen Haq | Endocrinology and Metabolism | Best Researcher Award
Asst Program Director at AAMC Medical Center Internal Medicine Residency program and division of endocrinology, metabolism,United States
Dr. Nowreen Haq, MD, MPH, is a highly accomplished physician-researcher with specialized expertise in endocrinology, metabolism, obesity, and preventive medicine. Her leadership as Principal Investigator at the NIH, particularly in machine learning-based clinical research, reflects a deep commitment to advancing evidence-based medicine. Dr. Haq has played key roles in academic institutions such as Johns Hopkins, NYU, and the University of Maryland, where she has influenced clinical education and residency program development. Her contributions to national committees and protocol development highlight her impact on healthcare policy and clinical standards. She has been recognized with multiple grants for quality improvement and patient safety initiatives, demonstrating her ability to translate research into meaningful outcomes. While greater visibility into her publication record could further bolster her profile, Dr. Haq’s multidisciplinary approach, clinical innovation, and dedication to improving patient care make her a strong and deserving candidate for the Best Researcher Award.
Professional Profile
Education🎓
Dr. Nowreen Haq has an extensive and distinguished educational background that spans international and U.S. institutions. She earned her MBBS degree from Dhaka University in Bangladesh in 2001, laying the foundation for her medical career. She then pursued a Master of Public Health (MPH) from the prestigious Johns Hopkins Bloomberg School of Public Health in 2006, where she gained advanced training in public health and preventive medicine. Dr. Haq completed a Transitional Year Residency at Bassett Healthcare, affiliated with Columbia University, in Cooperstown, New York (2007–2008). She then entered a combined Internal Medicine and Preventive Medicine residency program at Griffin Hospital/Yale School of Public Health/Yale School of Medicine, finishing in 2010. Her academic journey reflects a commitment to excellence, integrating clinical medicine with public health. Dr. Haq is board-certified in Internal Medicine, Endocrinology & Metabolism, and Obesity Medicine, demonstrating a multidisciplinary expertise that enhances both her clinical practice and research contributions.
Professional Experience📝
Dr. Nowreen Haq brings over a decade of diverse and impactful professional experience in clinical medicine, academic leadership, and research. She currently serves as a Physician Executive and Endocrinologist at Luminis Healthcare, where she also holds the role of Assistant Program Director for the Internal Medicine Residency Program. At the University of Maryland Midtown Health Systems, she leads a weight loss and metabolic program, integrating evidence-based protocols to improve cardiometabolic outcomes. Previously, she held clinical and leadership roles at institutions such as Chase Brexton Healthcare, Greater Baltimore Medical Center, NYU Langone, and Johns Hopkins Bayview Medical Center. Dr. Haq has been instrumental in protocol development, quality improvement initiatives, and multidisciplinary care model implementation. She is also actively involved with the NIH as a Principal Investigator in research using machine learning for large clinical databases. Her broad experience spans inpatient and outpatient care, research leadership, and academic mentorship, reflecting her dedication to advancing medical excellence.
Research Interest🔎
Dr. Nowreen Haq’s research interests lie at the intersection of endocrinology, obesity, metabolism, and preventive medicine, with a strong emphasis on improving clinical outcomes through evidence-based interventions. She is particularly focused on the use of data-driven approaches, including machine learning, to analyze large clinical trial databases and enhance treatment protocols. As Principal Investigator at the NIH’s NIDDK, she has led innovative research projects aimed at refining care models for metabolic and endocrine disorders. Dr. Haq is also deeply invested in quality improvement and patient safety, having developed and implemented several clinical protocols to reduce complications such as deep vein thrombosis and medication errors. Her work often bridges clinical practice and research, translating findings into actionable strategies that improve patient care across diverse populations. Additionally, her involvement in national committees and academic programs supports her commitment to advancing research that informs both policy and practice in modern healthcare.
Award and Honor🏆
Dr. Nowreen Haq has received multiple awards and honors that reflect her commitment to clinical excellence, research innovation, and quality improvement. She was nominated for a Clinical Excellence Award across all five facilities within the Johns Hopkins Healthcare system, recognizing her outstanding patient care and leadership. Dr. Haq is a two-time recipient of the prestigious Pyramid Small Grant for Patient Safety and Quality Improvement, awarded for her work on enhancing medication safety and preventing deep vein thrombosis in post-discharge patients. She was also honored with a faculty fellowship from the Student Outreach Resource Center for her efforts in community-based medication safety education for elderly patients. Additionally, she received a research grant from the Agency for Healthcare Quality and Research (AHRQ) to study the utilization of cardiac resynchronization therapy in Medicare patients. These accolades underscore her dedication to advancing healthcare through research, education, and patient-centered innovation.
Research Skill🔬
Dr. Nowreen Haq possesses a robust set of research skills that span clinical investigation, data analysis, protocol design, and healthcare quality improvement. As a Principal Investigator at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), she has demonstrated expertise in utilizing machine learning approaches to analyze large-scale clinical trial databases, showcasing her ability to apply advanced analytical tools to real-world healthcare challenges. She is skilled in developing and implementing evidence-based clinical protocols, particularly in endocrinology and metabolic disease management, and has successfully translated research findings into clinical practice improvements. Dr. Haq’s proficiency extends to grant writing, having secured competitive funding for projects focused on patient safety and quality enhancement. Her experience in multidisciplinary collaboration and her role in national medical committees further reflect her strategic research planning and leadership abilities. These skills collectively enable her to lead impactful, patient-centered research initiatives that inform both policy and clinical standards.
Conclusion💡
Dr. Nowreen Haq is exceptionally qualified for the Best Researcher Award, particularly due to her blend of clinical excellence, leadership in protocol development, innovative research using machine learning, and strong academic roles. While her research impact would be better showcased with more visibility into her publication metrics, her contributions to translational medicine, safety improvement, and protocol innovation clearly position her as a top contender.
Publications Top Noted✍
-
Title: Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk
Authors: M Mongraw-Chaffin, MC Foster, CAM Anderson, GL Burke, N Haq, …
Year: 2018
Citations: 436
Journal: Journal of the American College of Cardiology, 71(17), 1857–1865 -
Title: Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis
Authors: SG Coca, F Ismail-Beigi, N Haq, HM Krumholz, CR Parikh
Year: 2012
Citations: 373
Journal: Archives of Internal Medicine, 172(10), 761–769 -
Title: Predictors of response to cardiac resynchronization therapy: a systematic review
Authors: J Rickard, H Michtalik, R Sharma, Z Berger, E Iyoha, AR Green, N Haq, …
Year: 2016
Citations: 98
Journal: International Journal of Cardiology, 225, 345–352 -
Title: Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure
Authors: HJ Michtalik, HC Yeh, CY Campbell, N Haq, H Park, W Clarke, …
Year: 2011
Citations: 82
Journal: The American Journal of Cardiology, 107(8), 1191–1195 -
Title: Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice
Authors: LS Lim, N Haq, S Mahmood, L Hoeksema, ACPM Committee
Year: 2011
Citations: 81
Journal: American Journal of Preventive Medicine, 40(3), 381.e1–381.e10